Search results
Precigen Reports First Quarter 2024 Financial Results and Business Updates
WRBL Columbus· 3 days ago– Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation ...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
Reuters via Yahoo News· 2 days agoThe Food and Drug Administration's decision marks the fourth approval for Breyanzi, which can now be...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoOutside of primary chemotherapy, there is no universal treatment decision path to determine the...ovarian cancer patients from 2010 through 2016, a broad array of inputs, including patient data ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoEHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress PR Newswire ...
Special counsel accused of 'grotesquely dishonest' exhibits in Hunter Biden case
The Raw Story· 2 days agoNational security expert Marcy Wheeler has been closely following the Hunter Biden case while the...
My doctor told me I had dandruff but the lumps were cancer
Yahoo Life UK· 1 day agoI can’t tell you how quickly the time has flown by but mentally, the illness has affected me badly....
New bills push for sober housing throughout California
Channel 8 San Diego· 1 day agoState lawmakers are pushing for a new approach to solving homelessness. Two new bills would allow...
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 1 day agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat ...
Should California be able to require sobriety in homeless housing?
Napa Valley Register· 3 days agoDesperate for a way to help the tens of thousands of people living in tents, cars and RVs on...
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 1 day agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast...
